Dear researchers,
the Innovative Medicines Initiative latest call (Research and Innovation) has opened and is open for proposals from consortia. Topics:
* Topic 1: Returning clinical trial data to study participants within a GDPR compliant and approved ethical frameworkhttps://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/imi2-2020-23-01 * Topic 2: Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistancehttps://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/imi2-2020-23-02 This topic is part of IMI's Antimicrobial Resistance (AMR) Accelerator programme. * Topic 3: A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseaseshttps://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/imi2-2020-23-03 * Topic 4: Optimal treatment for patients with solid tumours in Europe through artificial intelligencehttps://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/imi2-2020-23-04 * Topic 5 Shortening the path to rare disease diagnosis by using new born genetic screening and digital technologieshttps://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/imi2-2020-23-05 * Topic 6: Behavioural model of factors affecting patient adherencehttps://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/imi2-2020-23-06 If you have plans in participating please contact me.
Best regards, Emma
************************ Emma Pirilä, PhD Research Funding Specialist Faculty of Medicine Faculty of Biochemistry and Molecular Medicine Biocenter Oulu Aapistie 5A, 2nd floor FIN- 90230 University of Oulu Finland Phone: +358503426428 e-mail: emma.pirila@oulu.fimailto:emma.pirila@oulu.fi ************************